Psilocybin Bests SSRI for Major Depression in First Long-Term Comparison

The first long-term comparison of psilocybin vs an SSRI for MDD suggests the psychedelic was associated with better overall efficacy and fewer side effects.

Medscape
We talk so much about precision healthcare, and sometimes it is as easy as measuring variation 12 genes to improve. Simply staggering!
Kudos to all involved👏👏
---
RT @MPUoL
A journey which started in 2016 has led to the publication of the #PREPARE study in @TheLancet today. In this #randomised study, we show that a 12-gene panel can reduce #adverse_effects by 30%. https://authors.elsevier.com/c/1gX95V-4XHGbk @CDSS_Liverpool @pandtuol
https://twitter.com/MPUoL/status/1621446599133040640